Overview
- Preventive has raised $30 million, is headquartered in San Francisco, and is structured as a public-benefit corporation.
- Reporting says the company is exploring countries where embryo editing is legal, with the United Arab Emirates cited as a possible venue.
- The venture aims to prevent hereditary disease by creating a child from an edited embryo and has reportedly identified a couple interested in participating.
- Germline editing intended to create a baby is illegal in the United States, the United Kingdom and many other countries, and scientists warn of unresolved safety and ethical risks.
- Founder Lucas Harrington trained in Jennifer Doudna’s CRISPR lab, and recent peer‑reviewed progress in infant gene‑editing therapies underscores broader scientific momentum.